We use cookies to give you a better Web experience. By visiting our website you agree to our use of cookies. Read about cookies
OK
  1. Home
  2. Mandates
  3. Vinge advises Calliditas in connection with a directed share issue

Assignment Vinge advises Calliditas in connection with a directed share issue

July 04, 2019

The Board of Directors of Calliditas Therapeutics AB (publ) (“Calliditas”) has resolved on a directed new issue of shares, whereby the company will raise proceeds of approximately SEK 210 million, before issue costs.

The share issue is directed to a number of selected international and Swedish reputable investors and life sciences specialist investors, on the basis of an accelerated bookbuilding process conducted by Carnegie Investment Bank and Zonda Partners.

Calliditas Therapeutics is a specialty pharmaceutical company based in Stockholm, Sweden. It is focused on developing high quality pharmaceutical products for patients with a significant unmet medical need in niche indications, in which the company can partially or completely participate in the commercialization efforts. 

Vinge’s team has consisted of Dain Hård Nevonen, Nils Fredrik Dehlin and Edin Agic.

Share

Insurance services in Sweden – a summary

 Vinge’s insurance team has written a brief summary of some of the main features of the Swedish regulations affecting foreign insurers with existing or contemplated business activities in Sweden.
February 10, 2020

Employment law podcast – our first episode in English

 By popular request, here is our very first English-language episode of Vinge's employment law podcast Arbetsrättspodden.
November 28, 2019

Viveka Classon new partner in Stockholm

 Viveka Classon has been elected as a new partner at Vinge’s Stockholm office.
November 14, 2019